MedTrace Logo

Effects of Oxytocin and Carbetocin on Renal System in Cesarean Sections

NCT03939806 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2019-05-13

No results posted yet for this study

Summary

The aim of this study is to evaluate the renal outcome of patients undergoing elective C/S where oxytocin or carbetocin is used for postpartum hemorrhage prophylaxis.

Conditions

  • Postpartum Hemorrhage

Interventions

DRUG

Oxytocin

To be given to Oxytocin group following the clamping of the umbilical cord

DRUG

Carbetocin

To be given to Carbetocin group following the clamping of the umbilical cord

Sponsors & Collaborators

  • Ufuk University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-31
Primary Completion
2019-06-30
Completion
2019-06-30
FDA Drug
Yes

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03939806 on ClinicalTrials.gov